Fujifilm boosts manufacturing capacity alongside R&D; Baxter International will invest $100M in BioPharma Solutions
Fujifilm Irvine Scientific is expanding an R&D center in California, and it’s boosting its manufacturing along with it.
The company announced Wednesday that it would expand its Armstrong R&D Center of Excellence at headquarters in Santa Ana, in order to commit to the advancement of discovery research, bioproduction, and cell and gene therapy among other things. But as its experienced a significant amount of revenue increase in the past year, and boasting of new manufacturing capabilities in Europe, the expansion will help aid those efforts.
In a statement, CSO Bob Newman said:
“With society’s increasing demand for global access to more high-quality, cost-effective vaccines, biopharmaceuticals, cell-based therapies, gene therapies, and in-vitro fertilization procedures, the need for a broadened focus on innovation is pivotal to expedite critical product and technology development. The expansion project will more than double the R&D facility’s footprint and will allow for more enhanced technical collaboration between R&D experts and customers to develop personalized solutions and enhance partnership opportunities.”
Baxter International will invest $100M in BioPharma Solutions
An Illinois manufacturer is getting a boost at its German site.
BioPharma Solutions has landed a $100 million investment from Baxter International to expand its sterile fill-finish manufacturing facility in Halle/Westfalen. Construction is set to start in 2022, and wrap up in 2024, and will help expand the company’s footprint, while adding an aseptic syringe filling line to meet demand for the product both in the US and Europe.
“Baxter’s manufacturing site in Halle/Westfalen is one of the most advanced facilities in our global network and has seen significant growth over the last several years,” Baxter BioPharma Solutions General Manager Marie Keeley said. “By making this investment, we are building on recent expansions to help ensure this facility can serve our partners at the highest level now and well into the future.”